Inborn Errors of Metabolism: Genetic Enzyme Defects and Clinical Consequences

Inborn errors of metabolism (IEM) are a heterogeneous group of genetic disorders caused by defects in enzymes, transporters, or cofactors involved in metabolic pathways. These defects disrupt the body's ability to properly convert nutrients into energy, synthesize essential compounds, or eliminate waste products.

Pathophysiology

Most IEMs result from mutations in genes encoding metabolic enzymes. The defective enzyme leads to:

  • Accumulation of toxic substrates upstream of the metabolic block
  • Deficiency of essential products downstream of the block
  • Activation of alternative pathways producing abnormal metabolites

These biochemical disturbances cause cellular dysfunction, organ damage, and systemic symptoms.

Clinical Presentation

Symptoms vary widely depending on the specific disorder and affected pathway, but may include:

  • Neurological deterioration, seizures, developmental delay
  • Growth failure, feeding difficulties, vomiting
  • Liver dysfunction, hepatomegaly
  • Cardiac abnormalities, cardiomyopathy
  • Muscle weakness, exercise intolerance
  • Characteristic facial features, skeletal abnormalities
  • Acute metabolic crises triggered by illness or fasting

Diagnosis and Management

Newborn screening using tandem mass spectrometry detects many IEMs at birth. Confirmatory testing includes enzyme assays, metabolite profiling, and molecular genetic testing. Management is disorder-specific and may involve:

  • Dietary restriction of offending substrates (e.g., phenylalanine in PKU)
  • Supplementation of deficient products (e.g., carnitine, cofactors)
  • Medications to enhance alternative pathways or reduce toxic accumulation
  • Organ transplantation for severe hepatic or cardiac involvement
  • Emergency protocols for metabolic decompensation

Early diagnosis and intervention significantly improve outcomes for many IEMs.

Genetic Disorders - Related Articles